Recent trends in mesoporous carbon-based nanoplatforms for biomedical application
Journal of Pharmaceutical Analysis · 2025-11 · 15 (11) · 101383
DOI: 10.1016/j.jpha.2025.101383 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-11. Verfasst von Wei Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang, 110004, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Province Doctoral Start-up Foundation, Liaoning Provincial Department of Human Resources and Social Security.
Abstract (Originalsprache)
Mesoporous carbon nanoparticles (MCNs) have received considerable attention for biomedical applications due to their unique structural features, including high specific surface area, adjustable pore size, and remarkable biocompatibility. These properties have addressed key challenges such as inefficiencies in drug loading and release, minimizing the side effects associated with conventional treatments. In this review, the classification and the research progress of MCNs are summarized firstly, the preparation and modification techniques to enhance their functionality and properties are further reviewed, the main physicochemical properties are introduced as well, highlighting their contributions to MCNs in applications. In addition, the biomedical applications of MCNs are emphasized, including tumor therapy, tumor theranostics, antibacterial, delivery of active molecules and biological detection. Finally, the prospects and challenges of clinical application based on MCNs are analyzed to provide an effective reference and lay the foundation for further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
- Department of General Surgery, The First Hospital of China Medical University, Shenyang, 110001, China.
- Department of Cardiology, The First Hospital of China Medical University, Shenyang, 110001, China.
- Department of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, China.
- School of Pharmacy, China Medical University, Shenyang, 110122, China.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Förderung
- Liaoning Province Doctoral Start-up Foundation
- Liaoning Provincial Department of Human Resources and Social Security
Zitieren
APA
Yang, W., Ge, J., Jiang, M., Zhang, N., Yang, Q., Nan, K., Zhao, Q., Wan, L., & Wang, X. (2025). Recent trends in mesoporous carbon-based nanoplatforms for biomedical application. Journal of Pharmaceutical Analysis, 15(11), 101383. https://doi.org/10.1016/j.jpha.2025.101383
Vancouver
Yang W, Ge J, Jiang M, Zhang N, Yang Q, Nan K, et al. Recent trends in mesoporous carbon-based nanoplatforms for biomedical application. Journal of Pharmaceutical Analysis. 2025;15(11):101383. doi:10.1016/j.jpha.2025.101383
BibTeX
@article{Yang2025,
author = {Yang, Wei and Ge, Jinnian and Jiang, Mohan and Zhang, Nan and Yang, Qinghe and Nan, Kaisheng and Zhao, Qinfu and Wan, Long and Wang, Xiaofan},
title = {Recent trends in mesoporous carbon-based nanoplatforms for biomedical application},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {11},
pages = {101383},
doi = {10.1016/j.jpha.2025.101383}
}
EUVIMED